After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses

A revolutionary drug, daraxonrasib, is changing the landscape of pancreatic cancer treatment by doubling survival times. Initially trialed at UCLA, it's showing promise beyond just pancreatic cancer, with the FDA fast-tracking its approval. Doctors and patients alike are eagerly anticipating its potential to redefine cancer therapy. #CancerResearch #PancreaticCancer #MedicalBreakthrough #FDAApproval #Oncology